A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
May 4, 2022
Primary Completion Date
June 9, 2022
Study Completion Date
June 20, 2022
Conditions
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers